The shares are now hovering at a premium of around ₹105-110 in the grey market— which is an upside of 7% over the issue price band. The shares of the recently concluded Gland Pharma IPO are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback